Glioma cell antioxidant capacity relative to reactive oxygen species produced by dopamine

Journal of Applied Toxicology

Volumn 24, Issue 2, 2004, Pages 99-106

  Mazzio, Elizabeth A ^a   Soliman, Karam F A ^a  

^a FLORIDA A AND M UNIVERSITY   (United States)

Author keywords

Astrocyte; Autoxidation; C6 cells; Catalase; Catecholamine; Dopamine; Hydrogen peroxide; Monoamine; Monoamine oxidase; Parkinson; Parkinson's disease

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIOXIDANT; BACTERIUM LIPOPOLYSACCHARIDE; BUTHIONINE SULFOXIMINE; CATALASE; CYTOKINE; DOPAMINE; ENDOTOXIN; GAMMA INTERFERON; HYDROGEN PEROXIDE; NITRIC OXIDE; NITRITE; NITROPRUSSIDE SODIUM; REACTIVE OXYGEN METABOLITE; SELEGILINE; SODIUM AZIDE; SUPEROXIDE; TYRAMINE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; ATTENUATION; AUTOOXIDATION; BACTERIAL STRAIN; CELL LYSATE; CELL STRAIN; CONTROLLED STUDY; DISSOLUTION; ENZYME ACTIVITY; ENZYME ISOLATION; ENZYME MECHANISM; ENZYME SUBSTRATE; ESCHERICHIA COLI; EXPOSURE; GLIOMA CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; SCAVENGING SYSTEM; SUPERNATANT;

ANIMALS; ANTIOXIDANTS; CELL LINE, TUMOR; CELL SURVIVAL; DOPAMINE; DRUG COMBINATIONS; GLIOMA; HYDROGEN PEROXIDE; INTERFERON TYPE II; LIPOPOLYSACCHARIDES; MONOAMINE OXIDASE; NEURONS; NITRIC OXIDE; OXIDATION-REDUCTION; RATS; REACTIVE OXYGEN SPECIES; SUPEROXIDES;

ESCHERICHIA COLI; GYMNOMYZA SAMOENSIS;

EID: 1842767270     PISSN: 0260437X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jat.954     Document Type: Article

References (37)

1. Baker K, Marcus CB, Huffman K, Kruk H, Malfroy B, Doctrow SR. 1998. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J. Pharmacol. Exp. Ther. 284: 215-221.
2. Ben Shacar D, Eshel G, Finberg JP, Youdim MB. 1991. The iron chelator desferrioxamine (Desferal) retards 6-hydroxydopamine-induced degeneration of nigrostriatal dopamine neurons. J. Neurochem. 56: 1441-1444.
3. Blum D, Torch S, Lambeng N, Nissou M, Benabid AL, Sadoul R, Verna JM. 2001. Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease. Prog. Neurobiol. 66: 135-172.
4. Ciriolo MR, Marasco MR, Iannone M, Nistico G, Rotilio G. 1997. Decrease of immunoreactive catalase protein in specific areas of ageing rat brain. Neurosci. Lett. 228: 21-24.
5. + binding sites in the brain of various mammalian species. J. Neural Transm. Park. Dis. Dement. 4: 181-190.
6. Desagher S, Glowinski J, Premont J. 1996. Astrocytes protect neurons form hydrogen peroxide toxicity. J. Neurosci. 16: 2553-2562.
7. Double KL, Maywald M, Schmittel M, Riederer P, Gerlach M. 1998. In Vitro studies of ferritin iron release and neurotoxicity. J. Neurochem. 70: 2492-2499.
8. Drukarch B, Schepens E, Jongenelen CA, Stoof JC, Langeveld CH. 1997. Astrocyte-mediated enhancement of neuronal survival is abolished by glutathione deficiency. Brain Res. 770: 123-130.
9. Evans SM, Casartelli A, Herreros E, Minnick DT, Day C, George E, Westmoreland C. 2001. Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potential. Toxicol. In Vitro 15: 579-584.
10. Fowler JS, Volkow ND, Wang GJ, Logan J, Pappas N, Shea C, MacGregor R. 1997. Age-related increases in brain monoamine oxidase B in living healthy human subjects. Neurobiol. Aging 18: 431-435.
11. Gupta A, Datta M, Shukla GS. 2000. Cerebral antioxidant status and free radical generation following glutathione depletion and subsequent recovery. Mol. Cell Biochem. 209: 55-61.
12. Hirrlinger J, Gutterer JM, Kussmaul L, Hamprecht B, Dringen R. 2000. Microglial cells in culture express a prominent glutathione system for the defense against reactive oxygen species. Dev. Neurosci. 22: 384-392.
13. Holt A, Sharman DF, Baker GB, Palcic MM. 1997. A continuous spectrophotometric assay for monoamine oxidase and related enzymes in tissue homogenates. Anal. Biochem. 244: 384-392.
14. Hong JT, Ryu SR, Kim HJ, Lee JK, Lee SH, Kim DB, Yun YP, Ryu JH, Lee BM, Kim PY. 2000. Neuroprotective effect of green tea extract in experimental ischemia-reperfusion brain injury. Brain Res. Bull. 53: 743-749.
15. Hothersall JS, Greenbaum AL, McLean P. 1982. The functional significance of the pentose phosphate pathway in synaptosomes: protection against peroxidative damage by catecholamines and oxidants. J. Neurochem. 39: 1325-1332.
16. Jaarsma D, Haasdijk ED, Grashorn JA, Hawkins R, van Duijn W, Verspaget HW, London J, Holstege JC. 2000. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1. Neurobiol. Dis. 7: 623-643.
17. Kitani K, Kanai S, Ivy GO, Carrillo MC. 1999. Pharmacological modifications of endogenous antioxidant enzymes with special reference to the effects of deprenyl: a possible antioxidant strategy. Mech. Ageing Dev. 111: 211-221.
18. Langeveld CH, Jongenelen CA, Schepens E, Stoof JC, Bast A, Drukarch B. 1995. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development. Neurosci. Lett. 192: 13-16.
19. Li SW, Lin T, Minteer S, Burke WJ. 2001. 3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis. Brain Res. Mol. Brain Res. 93: 1-7.
20. Lowry OH, Rosebrough NJ, Farr AL, Innis RB. 1951. Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275.
21. Lynch T, Cherny RA, Bush AI. 2000. Oxidative processes in Alzheimer's disease: the role of beta-metal interactions. Exp. Gerontol. 35: 445-451.
22. Magnani E, Bettini E. 2000. Resazurin detection of energy metabolism changes in serum-starved PC12 cells and of neuroprotective agent effect. Brain Res. Brain Res. Protocol. 5: 266-272.
23. Maruyama W. 2001. Pathogenesis of idiopathic Parkinson's disease. Nippon Ronen Igakkai Zasshi 38: 494-497.
24. McNaught KS, Jenner P. 2000. Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation. Biochem. Pharmacol. 60: 979-988.
25. Naoi M, Maruyama W, Takahashi T, Akao Y, Nakagawa Y. 2000. Involvement of endogenous N-methyl(R) salsolinol in Parkinson's disease: induction of apoptosis and protection by (-) deprenyl. J. Neural Transm. Suppl. 58: 111-121.
26. Nwanze E, Souverbie F, Jonsson G. 1995. Sundstrom E. Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity. Neurotoxicology 16: 469-477.
27. O'Malley EK, Sieber BA, Black IB, Dreyfus CF. 1992. Mesencephalic type I astrocytes mediate the survival of substantia nigra dopaminergic neurons in culture. Brain Res. 582: 65-70.
28. Park SK, Murphy S. 1994. Duration of expression of inducible nitric oxide synthase in glial cells. J. Neurosci. Res. 39: 405-411.
29. Pick E, Mizel D. 1981. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophages in culture using an automatic enzyme immunoassay reader. J. Immunol. Methods 46: 211-226.
30. Sokolova T, Gutterer JM, Hirrlinger J, Hamprecht B, Dringen R. 2001. Catalase in astroglia-rich primary cultures from rat brain: immunocytochemical localization and inactivation during the disposal of hydrogen peroxide. Neurosci. Lett. 297: 129-132.
31. Takeda H, Tomita M, Tanahashi N, Kobari M, Yokoyama M, Takao M, Ito D, Fukuuchi Y. 1998. Hydrogen peroxide enhances phagocytic activity of ameboid microglia. Neurosci. Lett. 240: 5-8.
32. Thompson KJ, Shoham S, Connor JR. 2001. Iron and neurodegenerative disorders. Brain Res. Bull. 55: 155-164.
33. Turnbull S, Tabner BJ, El-Agnaf OM, Moore S, Davies Y, Allsop D. 2001. Alpha-Synuclein implicated in Parkinson's disease catalyses the formation of hydrogen peroxide in vitro. Free Radic. Biol. Med. 30: 1163-1170.
34. Wang XF, Cynader MS. 2000. Astrocytes provide cysteine to neurons by releasing glutathione. J. Neurochem. 74: 1434-1442.
35. Youdim MB, Lavie L. 1994. Selective MAO-A and B inhibitors, radical scavengers and nitric oxide synthase inhibitors in Parkinson's disease. Life Sci. 55: 2077-2082.
36. Yu PH, Zuo DM. 1997. Enhanced tolerance of neuroblastoma cells towards the neurotoxin 6-hydroxydopamine following specific cell-cell interaction with primary astrocytes. Neuroscience 178: 903-912.
37. Zeng YC, Bongrani S, Bronzetti E, Cadel S, Ricci A, Valsecchi B. 1995. Amenta Effect of Long-term treatment with L-Deprenyl on the age-dependent microanatomical changes in the rate hippocampus. Mech. Ageing Dev. 79: 169-185.